Immunocore Holdings plc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Oxfordshire, United Kingdom
IMCR chart
What traders are saying about $IMCR
Latest postsImmunocore Holdings plc news
- HC Wainwright & Co. maintains Immunocore Holdings at Buy, lowers price target to $80 from $100
TradingView ·
- Convertible notes are part of Steven A. Cohen’s reported Immunocore (IMCR) stake.
Stock Titan ·
- Immunocore doubles up on T-cell engagers in eye cancer
European Biotechnology Magazine ·
- Immunocore to present at UBS and Jefferies inve...
Pluang ·
- Immunocore to present at upcoming investor conferences
Yahoo Finance ·
- Is Immunocore Holdings (IMCR) Undervalued On Third Quarter Earnings?
Simply Wall St ·
- Immunocore Stock Is Up 9.1% Has The Bull Case Changed?
Simply Wall St ·
- Immunocore Holdings plc (IMCR) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Immunocore Holdings plc (IMCR) stock price, news, quote and history
Yahoo Finance UK ·
- Immunocore Holdings Stock Price Forecast. Should You Buy IMCR?
StockInvest.us ·
- Immunocore to take dual-targeting combo regimen into next phase in eye cancer
FirstWord Pharma ·
- Form 8K Immunocore Holdings plc For: 6 November By Investing.com
Investing.com Nigeria ·
Immunocore Holdings plc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $400.0M | $310.2M | $249.4M | $174.4M |
| Net income | -$35.5M | -$51.1M | -$55.3M | -$52.5M |
| Diluted EPS | $-0.71 | $-1.02 | $-1.13 | $-1.15 |
| Total assets (year end) | $1.07B | $1.01B | $597.0M | $526.8M |
| Cash and equivalents (year end) | $467.7M | $455.7M | $442.6M | $402.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Immunocore Holdings plc
- Ticker
- IMCR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Oxfordshire, United Kingdom
- Incorporated in
- United Kingdom
- Fiscal year end
- December 31
- SEC CIK
- 1671927
- Former names
- Immunocore Ltd
Frequently asked questions
What exchange is Immunocore Holdings plc listed on?
Immunocore Holdings plc trades on the Nasdaq under the ticker symbol IMCR.
What industry is Immunocore Holdings plc in?
Immunocore Holdings plc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Immunocore Holdings plc headquartered?
Immunocore Holdings plc's business address on file with the SEC is in Oxfordshire, United Kingdom.
When does Immunocore Holdings plc's fiscal year end?
Immunocore Holdings plc's fiscal year ends on December 31.
How much revenue did Immunocore Holdings plc report?
Immunocore Holdings plc reported $400.0M in revenue for calendar year 2025, according to its SEC filings.